Vanguard Group’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $6.8K | Buy |
|
|||||
2024
Q4 | $7.67K | Hold |
|
|||||
2024
Q3 | $27.4K | Hold |
|
|||||
2024
Q2 | $47.8K | Hold |
|
|||||
2024
Q1 | $62.6K | Hold |
|
|||||
2023
Q4 | $46.8K | Buy |
|
|||||
2023
Q3 | $54.3K | Buy |
|
|||||
2023
Q2 | $43.1K | Hold |
|
|||||
2023
Q1 | $64.8K | Sell |
|
|||||
2022
Q4 | $93.6K | Sell |
|
|||||
2022
Q3 | $220K | Sell |
|
|||||
2022
Q2 | $590K | Sell |
|
|||||
2022
Q1 | $2.64M | Sell |
|
|||||
2021
Q4 | $5.46M | Buy |
|
|||||
2021
Q3 | $5.06M | Buy |
|
|||||
2021
Q2 | $7.37M | Buy |
|
|||||
2021
Q1 | – | Sell |
|
|||||
2020
Q4 | $36K | Hold |
|
|||||
2020
Q3 | $28K | Hold |
|
|||||
2020
Q2 | $36K | Hold |
|
|||||
2020
Q1 | $25K | Hold |
|
|||||
2019
Q4 | $36K | Hold |
|
|||||
2019
Q3 | $55K | Hold |
|
|||||
2019
Q2 | $62K | Hold |
|
|||||
2019
Q1 | $65K | Hold |
|
|||||
2018
Q4 | $32K | Sell |
|
|||||
2018
Q3 | $95K | Hold |
|
|||||
2018
Q2 | $94K | Hold |
|
|||||
2018
Q1 | $144K | Buy |
|
|||||
2017
Q4 | $71K | Sell |
|
|||||
2017
Q3 | $108K | Hold |
|
|||||
2017
Q2 | $120K | Buy |
|
|||||
2017
Q1 | $120K | Hold |
|
|||||
2016
Q4 | $115K | Buy |
|
|||||
2016
Q3 | $92K | Sell |
|
|||||
2016
Q2 | $143K | Buy |
|
|||||
2016
Q1 | $99K | Hold |
|
|||||
2015
Q4 | $106K | Hold |
|
|||||
2015
Q3 | $210K | Hold |
|
|||||
2015
Q2 | $152K | Hold |
|
|||||
2015
Q1 | $273K | Buy |
|
|||||
2014
Q4 | $282K | Hold |
|
|||||
2014
Q3 | $206K | Hold |
|
|||||
2014
Q2 | $331K | Buy |
|
|||||
2014
Q1 | $239K | Hold |
|
|||||
2013
Q4 | $223K | Buy |
|
|||||
2013
Q3 | $107K | Hold |
|
|||||
2013
Q2 | $119K | Buy |
|